ACAD
ACADIA Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.97
+0.38%Forward multiples
Based on analyst estimates
- P/E forward
- 31.81x
- P/E 2026E
- 45.64x
- P/E 2027E
- 30.78x
- P/E 2028E
- 18.05x
- P/S forward
- 3.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.43x
- PEG TTM
- —
- Price / book
- 3.69x
- Price / sales
- 4.23x
- Price / cash flow
- 24.80x
Enterprise value
- Enterprise value
- $3.9B
- EV / sales
- 3.46x
- EV / EBITDA
- 33.90x
- EV / EBIT
- 45.57x
- Market cap
- $4.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026